TCL Archive Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years May 9, 2014
TCL Archive In Brief: NCI To Work More Closely With Biotherapeutics, DeVita Says; apportionment May Be Abolished February 12, 1988
TCL Archive NCI Initiatives: Two RFAs Planned In New Technologies for Molecular Biology December 6, 1996
TCL Archive NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis” May 7, 1993
TCL Archive FDA Commissioner Mark McClellan tells NCI audience that science is far from eliminating cancer as a threat. February 6, 2004
